Sphingolipids and S1P indirectly impact the PI3K/Akt signaling pathway by altering insulin receptor autophosphorylation and insulin receptor substrate (IRS) protein activity, which weakens insulin signaling and contributes to insulin resistance development. Here, INS is linked to Insulin resistance.